Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Filipa Lynce, M.D.

Concepts (191)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms820241464.320 Why?
Breast Neoplasms342024210172.170 Why?
BRCA2 Protein920247981.610 Why?
BRCA1 Protein9202411471.430 Why?
Receptor, erbB-210202425531.420 Why?
Paclitaxel3202417281.000 Why?
Neoadjuvant Therapy13202428210.900 Why?
Antineoplastic Combined Chemotherapy Protocols122024117090.890 Why?
Pyrazoles2202419880.790 Why?
Nitriles220249570.760 Why?
Ovarian Neoplasms4202348760.710 Why?
Platinum120212180.670 Why?
Antineoplastic Agents92024135910.650 Why?
Ventricular Dysfunction, Left2201921150.560 Why?
Anthracyclines320202820.530 Why?
Clinical Trials, Phase I as Topic120173260.530 Why?
Neutropenia120218840.520 Why?
Camptothecin320245880.500 Why?
Immunoconjugates420249490.500 Why?
Angiotensin-Converting Enzyme Inhibitors2201915030.490 Why?
Pyrimidines2202430060.460 Why?
Central Nervous System Neoplasms120229160.460 Why?
Medically Underserved Area120152570.440 Why?
Adrenergic beta-Antagonists1201912400.430 Why?
Molecular Targeted Therapy3201927960.420 Why?
Genes, BRCA2120156030.400 Why?
Genes, BRCA1120157650.380 Why?
Vulnerable Populations120156990.350 Why?
Female4720243903230.340 Why?
Troponin I220176320.330 Why?
Genetic Testing4202435300.330 Why?
Troponin T220177610.320 Why?
Patient Selection3202142440.310 Why?
Maytansine22019860.290 Why?
Urban Population1201520250.290 Why?
Cyclin-Dependent Kinase 6220223450.280 Why?
Humans5720247584060.280 Why?
Ovariectomy220206100.270 Why?
Population Surveillance1201526060.240 Why?
Neoplasm Recurrence, Local6202492730.210 Why?
Brain Neoplasms1202489810.210 Why?
Lymphoma1201118960.200 Why?
Protein Kinase Inhibitors1201856290.200 Why?
Angiogenesis Inhibitors1201220470.190 Why?
Mutation72022299150.190 Why?
Weight Gain1201123460.190 Why?
Omeprazole120211050.180 Why?
Survivors1201123700.180 Why?
Poly(ADP-ribose) Polymerases120234250.180 Why?
Neoplasm Staging72023111520.180 Why?
Phthalazines120233820.180 Why?
Neoplasms32019220320.180 Why?
Receptors, Estrogen3202222100.170 Why?
Lisinopril12019550.170 Why?
Genetic Predisposition to Disease32024177680.170 Why?
Urogenital System12019880.160 Why?
Piperazines2202125110.160 Why?
Prognosis42023295570.160 Why?
Treatment Outcome92024643780.160 Why?
Cyclin-Dependent Kinase 4220225550.160 Why?
Germ-Line Mutation2202418400.150 Why?
Estrogen Receptor alpha120225800.150 Why?
Middle Aged2120242195680.150 Why?
Antimetabolites, Antineoplastic120216380.150 Why?
Carboplatin120217880.150 Why?
Pyridines2202128590.150 Why?
Cardiac Imaging Techniques120202670.150 Why?
Brain12024269470.140 Why?
Maximum Tolerated Dose120198760.140 Why?
Lymphedema120235240.140 Why?
Genetic Counseling220236240.140 Why?
National Cancer Institute (U.S.)120172960.130 Why?
Antibiotics, Antineoplastic120206750.130 Why?
Aged1220211682180.130 Why?
Adult1620212199350.130 Why?
District of Columbia120151600.130 Why?
Central Nervous System1202213330.120 Why?
Cell Adhesion Molecules1202116000.120 Why?
Purines120186050.120 Why?
Mastectomy1202318320.120 Why?
Neoplasms, Second Primary1202210560.120 Why?
Genetic Heterogeneity120187230.120 Why?
Jews120163640.120 Why?
Aminopyridines120185640.120 Why?
DNA Copy Number Variations1202320120.120 Why?
Neoplasm Metastasis2202449010.110 Why?
Breast1202319630.110 Why?
Endometrial Neoplasms1202313570.110 Why?
Retrospective Studies62023801680.110 Why?
Interleukin-61202432080.110 Why?
Neovascularization, Pathologic1202426380.110 Why?
Neoplastic Cells, Circulating120209380.110 Why?
RNA1202327160.110 Why?
Benzimidazoles120188550.110 Why?
Estrogens1201915200.100 Why?
Drug Resistance, Neoplasm2202452490.100 Why?
Time Factors52021398720.100 Why?
Radiation Injuries1201911820.100 Why?
Chemotherapy, Adjuvant4202335270.090 Why?
Tumor Microenvironment1202438400.090 Why?
Obesity22023128700.090 Why?
Disease-Free Survival3202168210.090 Why?
Carrier Proteins1202449380.090 Why?
Ventricular Function, Left3202138580.090 Why?
Germ Cells220246350.080 Why?
Cytokines1202473380.080 Why?
Risk Reduction Behavior1201510980.080 Why?
Aged, 80 and over52021586830.080 Why?
Hippocratic Oath12008160.080 Why?
Young Adult62020588080.080 Why?
Neoplasm, Residual2202410070.070 Why?
Dose-Response Relationship, Drug12019107480.070 Why?
Heart Diseases1202027820.070 Why?
DNA Repair1201620380.070 Why?
Pilot Projects1201985530.060 Why?
Drug Approval120128080.060 Why?
Antigens, Neoplasm2202319970.060 Why?
Echocardiography1201749620.060 Why?
Heart Failure12008115930.060 Why?
Incidence12022212720.060 Why?
Risk1201695990.060 Why?
Neuropilin-112024900.060 Why?
Heart1201743820.060 Why?
Neoplasm Proteins1201636090.060 Why?
Registries2202081750.060 Why?
Pamphlets12023710.050 Why?
Risk Assessment42024238840.050 Why?
Age Factors32017183580.050 Why?
Risk Factors62023738090.050 Why?
Ki-67 Antigen120236310.050 Why?
Gene Expression Profiling1201794040.050 Why?
Review Literature as Topic120233480.050 Why?
Animals420241677680.050 Why?
Axilla120236260.050 Why?
Body Weight1201146030.050 Why?
Prospective Studies32023541370.050 Why?
Genomics1201657900.040 Why?
Stroke Volume3202154600.040 Why?
Evidence-Based Medicine1201236710.040 Why?
Telephone120236250.040 Why?
Prevalence12016156510.040 Why?
Administration, Intravaginal120191510.040 Why?
Taxoids120226680.040 Why?
Sentinel Lymph Node Biopsy120237330.040 Why?
Aromatase Inhibitors120225110.040 Why?
Sex Factors12011105040.040 Why?
High-Throughput Nucleotide Sequencing2202136150.040 Why?
Ubiquitin Thiolesterase120204540.040 Why?
Lymph Node Excision1202313030.040 Why?
Logistic Models12011132760.030 Why?
Quality of Life22022132850.030 Why?
Neoplastic Stem Cells1202413460.030 Why?
Receptors, Androgen1202210770.030 Why?
United States32020721360.030 Why?
Diarrhea1202213170.030 Why?
Ligands1202232580.030 Why?
Early Diagnosis1202011770.030 Why?
Tumor Burden1202118930.030 Why?
Predictive Value of Tests22021152250.030 Why?
Atrophy1201916270.030 Why?
Body Mass Index12011128760.030 Why?
Gynecology120195280.030 Why?
Sensitivity and Specificity12008146410.030 Why?
Cardiovascular Diseases12019153990.030 Why?
Adolescent22020878920.030 Why?
Radiotherapy1201915040.020 Why?
Health Care Surveys1201924320.020 Why?
Qualitative Research1202229760.020 Why?
DNA Damage1202024390.020 Why?
Tumor Suppressor Proteins1202028000.020 Why?
Male320193587470.020 Why?
Caregivers1202222250.020 Why?
DNA Mutational Analysis1201841060.020 Why?
Doxorubicin1201622090.020 Why?
Mutation, Missense1201825640.020 Why?
Survival Analysis12021101120.020 Why?
Immunotherapy1202446410.020 Why?
Cell Line, Tumor12024168860.020 Why?
Randomized Controlled Trials as Topic12024101460.020 Why?
Kaplan-Meier Estimate1201764930.020 Why?
Health Status Disparities1201818310.020 Why?
Medication Adherence1201721550.020 Why?
Odds Ratio1201796500.010 Why?
Recurrence1201784260.010 Why?
Databases, Factual1202079800.010 Why?
Health Knowledge, Attitudes, Practice1201939920.010 Why?
Physicians1201945800.010 Why?
Follow-Up Studies12021390590.010 Why?
Cross-Sectional Studies12019259560.010 Why?
Mice12024811010.010 Why?
Cohort Studies12018412560.010 Why?
Lynce's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (191)
Explore
_
Co-Authors (58)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.